Understanding the heterogeneity of IL-6 responses is essential for several reasons:
Personalized Medicine: Tailoring treatments based on individual IL-6 profiles can improve therapeutic outcomes, especially in conditions like rheumatoid arthritis and chronic inflammatory diseases. Public Health Interventions: Identifying populations with higher IL-6 levels can help in developing targeted public health strategies to mitigate risks associated with chronic diseases. Predictive Biomarkers: IL-6 can serve as a predictive biomarker for disease progression and response to treatment, making it valuable in clinical and epidemiological research.
